中国中药(00570.HK)公布,国药集团拟私有化的计划告吹,因为其境外直接投资未获批准。私有化的计划先决条件,即境外直接投资批准于上周五(10月18日)仍未得到满足,而先决条件最后截止日期并未延长。因此,私有化建议于上周五(10月18日)失效。中国中药(00570.HK)股份在联交所的上市地位将不会撤销。版权声明:所有瑞恩资本Ryanben Capital的原创文章,转载须联系授权,并在文首/...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.